Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income from Non-Controlling Interests (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Income from Non-Controlling Interests for 9 consecutive years, with $19.8 million as the latest value for Q1 2026.

  • For Q1 2026, Income from Non-Controlling Interests rose 9.58% year-over-year to $19.8 million; the TTM value through Mar 2026 reached $36.6 million, down 24.31%, while the annual FY2025 figure was $68.3 million, 17.36% down from the prior year.
  • Income from Non-Controlling Interests hit $19.8 million in Q1 2026 for Select Medical Holdings, up from $17.6 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $25.4 million in Q3 2024 and bottomed at -$17.8 million in Q1 2024.
  • Average Income from Non-Controlling Interests over 5 years is $4.6 million, with a median of $11.0 million recorded in 2022.
  • Year-over-year, Income from Non-Controlling Interests tumbled 161.93% in 2023 and then surged 201.15% in 2025.
  • Select Medical Holdings' Income from Non-Controlling Interests stood at $10.2 million in 2022, then skyrocketed by 52.13% to $15.5 million in 2023, then rose by 27.54% to $19.8 million in 2024, then decreased by 11.3% to $17.6 million in 2025, then increased by 12.59% to $19.8 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $19.8 million, $17.6 million, and $15.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.